barium has been researched along with Drug Withdrawal Symptoms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Funada, M; Sato, M; Wada, K | 1 |
Aston-Jones, G; Ivanov, A | 1 |
2 other study(ies) available for barium and Drug Withdrawal Symptoms
Article | Year |
---|---|
Barium potentiates the conditioned aversion to, but not the somatic signs of, morphine withdrawal in mice.
Topics: Animals; Barium; Behavior, Animal; Cerebral Cortex; Conditioning, Operant; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Male; Mice; Mice, Inbred ICR; Morphine; Naltrexone; Narcotic Antagonists; Norepinephrine; Prosencephalon; Substance Withdrawal Syndrome | 2005 |
Local opiate withdrawal in locus coeruleus neurons in vitro.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Analgesics, Opioid; Animals; Barium; Bicuculline; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; GABA Antagonists; In Vitro Techniques; Kynurenic Acid; Locus Coeruleus; Male; Membrane Potentials; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Neurons; Ouabain; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Tetrodotoxin; Thionucleotides | 2001 |